Clinical application of three-dimensional myocardial imaging: Evaluation of efficacy of medical treatment on myocardial perfusion

Annals of Nuclear Medicine

Volumn 10, Issue 4, 1996, Pages 383-389

  Yamazaki, Junichi ^a   Hosoi, Hiromitsu ^a   Ishiguro, Satoshi ^a   Muto, Hiroshi ^a   Yamashina, Hisayo ^a   Morishita, Takeshi ^a   Takano, Masaaki ^a   Sugita, Junichi ^b   Takahashi, Munehiro ^c  

^a TOHO UNIVERSITY   (Japan)

^b KGT Corporation

^c SHIMADZU CORPORATION   (Japan)

Author keywords

myocardial perfusion; nisoldipine; surface rendering; thallium 201 myocardial single photon emission computed tomography; three dimensional myocardial imaging

Indexed keywords

NISOLDIPINE; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EXERCISE; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING;

EID: 0030482791     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03164798     Document Type: Article

References (17)

1. Yamazaki J, Ohsawa H, Uchi T, Iida M, Nakano H, Hosoi H, et al. Study of the efficacy of nicorandil in patients with ischaemic heart disease using exercise-Tl-201 myocardial tomography. Eur J Clin Pharmacol 44: 211-217, 1993.
2. Maddahi J, Garcia EV, Berman D, Waxman A, Swan HJC, Forrester J. Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of thallium-201. Circulation 64: 924-935, 1981.
3. Loboguerrero A, Perault C, Gibold C, Ouzan J, Pron T, Bouchard A, et al. Shape preserving three-dimensional display of myocardial scintigraphic data. Nucl Med Commun 15: 417-421, 1994.
4. Faber TL, Cooke CD, Prifer JW, Pettigrew RI, Vansant JP, Leyendecker JR, et al. Three-dimensional displays of left ventricular epicardial surface from standard cardiac SPECT perfusion quantification techniques. J Nucl Med 36: 697-703, 1995.
5. Slomka PJ, Hurwitz GA, Stephenson J, Cradduck T. Automated alignment and sizing of myocardial stress and rest to three-dimensional normal templates using an imaging registration algorithm. J Nucl Med 36: 1115-1122, 1995.
6. Ferretti PP, Borasi G, Salvo D, Serafini D, Versari A. Three-dimensional display of myocardial perfusion: detection of ischemic lesions using a new imaging subtraction method. Eur J Nucl Med 17: 55-60, 1990.
7. Faber TL, Akers MS, Peshock RM, Corbett JR. Three-dimensional motion and perfusion quantification in gated single-photon emission computed tomograms. J Nucl Med 32: 2311-2317, 1991.
8. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su H, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36: 2138-2147, 1995.
9. Siegel CS. Creating 3D models from medical images using AVS. 1995 international advanced visual systems users group conference proceedings, Boston, Massachusetts April 19-21, 1995: 424-431, 1995.
10. Tzivoni D, Banai S, Botvin S, Zilberman A, Weiss TA, Gavish A, et al. Effects of nisoldipine on myocardial ischemia during exercise daily activity. Am J Cordiol 67: 559-564, 1991.
11. Yokota M, Miyahara T, Iwase M, Watanabe M, Matsunami T, Kamihara S, et al. Hemodynamic mechanism of antianginal action of calcium channel blocker nisoldipine in dynamic exercise-induced angina. Circulation 81: 1887-1898, 1990.
12. Takahashi K, Taira N. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart. Arzneim - Forsch/Drug Res 36: 1054-1059, 1986.
13. Sakanishi M, Noguchi K, Kato T, Sunagawa R, Nakasone K. Comparison of vasodilating effects of nisoldipine and nifedipine in anesthetized open-chest dogs. Arzneim - Forsch/Drug Res 36: 1736-1739, 1986.
14. Lam J, Chaitman BR, Crean P, Blum R, Waters DD. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina. JACC 6: 447-452, 1985.
15. Lopez LM, Rubin MR, Holl JP. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients. Am Heart 7110: 991-996, 1985.
16. Brunelli C, Parodi O, Sambuceti G, Corsiglia L, Rosa GM, Giorgetti A, et al. Perfusional and metabolic effects of nisoldipine as shown by positron emission tomography after acute myocardial infarction. Am J Cardiol 75: 31E-35E, 1995.
17. Rousseau MF, Melin J, Benedict CR, Ahn S, Raphael D, Bornemann M, et al. Effects of nisoldipine therapy on myocardial perfusion and neurohormonal status in patients with severe ischaemic left ventricular dysfunction. Eur Heart J 15: 957-964, 1994.